Only 2% of patients with primary sclerosing cholangitis (PSC) received a cholangiocarcinoma diagnosis, and the diagnosis was not early enough for there to be a survival benefit. In patients with PSC, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results